As per a new report by Transprency Market Research (TMR), the global medical microbiology testing technologies market is characterized by intense rivalry in the key players. The strong growth in the established players, such as Abbott Laboratories, Becton, Dickinson and Co., Agilent Technologies, and Beckman Coulter Inc., points towards a high degree of competition in this market. These players are focusing aggressively on the development of new products, diversification in current offerings, and continued market penetration to maintain their supremacy over the next few years, reports the research study.
According to the report’s estimations, the worldwide market for medical microbiology testing technologies was worth US$2.1 bn in 2015. Surging at a CAGR of 5.40% over the period from 2016 to 2024, the market is anticipated to reach US$3.4 bn by the end of the forecast period, thanks to the growing demand for automation in the area of medical microbiology.
Demand for Medical Microbiology Testing Technologies to Remain Strong for Infectious Diseases
The report considers respiratory diseases, infectious diseases, and neurological diseases as the key indication segments of the global medical microbiology testing technologies market. Among these, the infectious diseases segment has been dominating the overall market and is expected to remain on the top over the next few years, on the grounds of the increasing incidence rate of infectious diseases across the world.
In terms of the geography, the report categorizes the worldwide market for medical microbiology testing technologies into the Middle East and Africa, North America, Asia Pacific, Latin America, and Europe. North America and Europe have surfaced as the leading regional markets for medical microbiology testing technologies. However, Europe will take the top most position in this market in the years to come. The rising demand for enhanced microbiology technologies in Europe is expected to support this regional market over the forecast period, states the research report.
Increasing Government Investments to Support Global Medical Microbiology Testing Technologies Market
“The global market for medical microbiology testing technologies is expected to gain tremendous momentum in the near future, thanks to the rise in government investments to increase the research activities in life sciences and medical and biological sciences,” says the author of this report. The market is also projected to be boosted by the increasing prevalence of infectious diseases, particularly in emerging economies.
On the other hand, the high cost incurred in the application of these technologies may limit their adoption in the near future, reflecting negatively on this market. The complicated application procedures will double up the difficulty the market is anticipated to face in the years to come, states the research report.
The review is based on a report by Transparency Market Research, titled “Medical Microbiology Testing Technologies Market (Indication - Respiratory Diseases, Neurological Diseases, and Infectious Diseases; Technology - Cell Culture, Microscopy, and Serology; Application - Diagnostic and Treatment Monitoring; End User - Hospital Labs, Pathology Labs, and Research Institutes) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024.”
The global medical microbiology testing technologies market has been segmented as below:
- Respiratory Diseases
- Neurological Diseases
- Infectious Diseases
- Cell Culture
- Treatment Monitoring
By End User
- Hospital Labs
- Pathology Labs
- Research Institutes
- North America
- Latin America
- Rest of Latin America
- Rest of Europe
- Asia Pacific (APAC)
- New Zealand
- Rest of Asia Pacific
- Middle East and Africa (MEA)
- Saudi Arabia
- Rest of MEA
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453